CHF 100’000 for Genknowme

FIT | 12 May 2020

Genknowme has obtained a Tech Seed loan of CHF 100’000 from the Foundation for Technological Innovation (FIT). Resulting from a collaboration with the Vaud University Hospital (CHUV) and Lausanne University, the start-up develops a blood test to help health professionals with patients trying to gain a healthier lifestyle.

Self-monitoring our weight, our physical activity, our diet or our sleep have become common activities thanks to numerical tools. Yet, it is difficult to link this data to our own health. Genknowme’s tool allows to determine one’s general health state and the behaviours that influence it, by establishing an epigenetic profile explaining how our genes interact with our environment. Specifically, Genknowme estimates biological age, a measure associated with health and longevity, and its link to environmental and lifestyle factors such as physical activity, diet, smoking or alcohol consumption. By analysing which factors are responsible for premature aging, Genknowme wants to help their end-customer prioritize actions for a healthier longevity and therefore initially targets clinics and doctors specialised in prevention, longevity and well-being.

Founded in 2019 by Semira and Sébastien Nusslé, the start-up can already rely on a team of five members, with experience in medicine, public health, biology, biotechnology, finance and marketing. They have obtained the support of Innosuisse, Innovaud, the Vaud Office for Economic Affairs and Innovation (SPEI), Venture Kick and the Assura Foundation. Genknowme has already raised a pre-seed round and is planning a seed round for the end of 2020, aiming for one million Swiss Francs.

“The FIT loan will help us fund a “fast-track” version of our epigenetic profile. Our clients will be able to access their results in 5 to 10 days instead of the current 4 to 6 weeks. Our prospective clients are particularly mindful to these waiting-times and we are the only ones on the market currently capable of offering this solution”, explains Sébastien Nusslé, CSO and co-founder of Genknowme. In the end, Genknowme wants to build a comprehensive health assessment tool, also enabling to foresee chronic diseases and to consequently adapt one’s life-style.

Sébastien Nusslé
CSO and co-founder

Useful links
Press Images